首页> 外文期刊>Human mutation >Germline mutations of the MSR1 gene in prostate cancer families from Germany.
【24h】

Germline mutations of the MSR1 gene in prostate cancer families from Germany.

机译:来自德国的前列腺癌家族中MSR1基因的种系突变。

获取原文
获取原文并翻译 | 示例
       

摘要

The MSR1 gene at 8p22 has been suggested as a candidate gene for hereditary prostate cancer because germline variants have been found to be associated with the disease. Aside from a single nonsense mutation (R293X) that was found repeatedly at low frequencies in several samples, little evidence has been gained by follow-up studies to confirm the gene's relevance for prostate cancer. Prompted by reasonable support for a linkage to 8p22, we sought to determine the mutation spectrum of MSR1 in our family sample. Screening of 139 probands (representing 139 prostate cancer families) revealed 15 novel and a total of 20 sequence variants within the 10 coding exons and their intronic proximities. Aside from the known mutation c.877C>T (R293X) present in two of our families, we identified a second nonsense allele (c.251C>G; S84X) and a splice-site mutation (c.818-1G>A) that results in mRNA instability (each in a single pedigree). The novel missense alleles were c.703C>T (H235Y), c.856C>T (P286S), c.905C>T (P302L), c.1193C>G (A398G), and c.1289A>G (K430R). Of the eight variants that affect the encoded protein (splice site, nonsense, and missense), only R293X as well as the polymorphism c.823C>G (P275A) were additionally present at remarkable frequencies in further samples of sporadic prostate cancer and controls. Of note, carriers of R293X were equally frequent in 367 sporadic prostate cancer cases (1.9%) and in 197 controls (2.0%). To our knowledge, our study is the first to demonstrate further loss of function variants of MSR1 apart from R293X. Nevertheless, the low frequencies of deleterious alleles, in addition to an apparently moderate penetrance, does not support MSR1 as a major susceptibility gene in this family sample.
机译:由于已经发现种系变体与该疾病有关,因此已建议将8p22处的MSR1基因作为遗传性前列腺癌的候选基因。除了在多个样本中以低频率反复发现的单个无义突变(R293X)外,后续研究几乎没有证据证实该基因与前列腺癌的相关性。在合理支持与8p22连锁的提示下,我们试图确定我们家庭样品中MSR1的突变谱。对139个先证者(代表139个前列腺癌家族)的筛查发现,在10个编码外显子及其内含子附近,共有15种新颖的突变和总共20种序列变异。除了我们两个家族中存在的已知突变c.877C> T(R293X)外,我们还鉴定出第二个无意义等位基因(c.251C> G; S84X)和一个剪接位点突变(c.818-1G> A)导致mRNA不稳定(每个谱系都有)。新型错义等位基因为c.703C> T(H235Y),c.856C> T(P286S),c.905C> T(P302L),c.1193C> G(A398G)和c.1289A> G(K430R) 。在影响编码蛋白的八个变体中(剪接位点,无义和错义),在散发性前列腺癌和对照的其他样本中,仅R293X以及多态性c.823C> G(P275A)的出现频率也很高。值得注意的是,R293X的携带者在367例散发性前列腺癌病例(1.9%)和197例对照(2.0%)中同样频繁。据我们所知,我们的研究是第一个证明除R293X以外MSR1功能变异进一步丧失的研究。但是,有害的等位基因的低频率,除了表面上中等的外显率外,不支持MSR1作为该家族样品中的主要易感基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号